Related Experiment Video
Updated: May 13, 2026

A Simple Flow Cytometric Method to Measure Glucose Uptake and Glucose Transporter Expression for Monocyte Subpopulations in Whole Blood
Published on: August 12, 2016
Diabetes and HIV: current understanding and future perspectives
Sanjay Kalra1, Navneet Agrawal
1Bharti Hospital, Kunjpura Road, Karnal 132001, India. brideknl@gmail.com
Insights
Managing diabetes in patients with HIV is crucial due to increased infection risks. Highly active antiretroviral therapy (HAART) can cause metabolic issues, complicating care and increasing cardiovascular risks.
Area of Science:
- Endocrinology
- Infectious Diseases
- Public Health
Background:
- Diabetes mellitus is a chronic disease associated with increased infection risk.
- Human Immunodeficiency Virus (HIV) infection significantly impacts diabetic patients, posing a major health concern.
- Highly active antiretroviral therapy (HAART) has transformed HIV into a chronic condition, leading to metabolic abnormalities like insulin resistance and diabetes.
Purpose of the Study:
- To summarize current understanding of diabetes and metabolic abnormalities in HIV-infected patients.
- To review management strategies for co-existent diabetes and HIV.
- To highlight recent challenges in diagnosing and managing this dual condition.
Main Methods:
- Literature review of studies on diabetes and HIV co-infection.
- Analysis of metabolic complications associated with HAART.
- Synthesis of current clinical guidelines and research findings.
Main Results:
- HIV and diabetes co-infection increases risks for cardiovascular and renal complications.
- Metabolic disturbances from HAART complicate diabetes management in HIV patients.
- Effective management is essential to reduce mortality and morbidity.
Conclusions:
- Appropriate management of co-existent diabetes and HIV is vital for improved patient outcomes.
- Addressing metabolic abnormalities in HIV-infected individuals is critical.
- Further research is needed to overcome diagnostic and therapeutic challenges.
Abstract:
Diabetes mellitus is a chronic disease with a higher risk of associated infections. HIV infection severely affects diabetic patients and acts as a significant health concern. Highly active antiretroviral therapy (HAART) has changed HIV from an acute infection to a chronic infection with associated significant metabolic abnormalities such as insulin resistance, impaired glucose tolerance, metabolic syndrome, diabetes, dyslipidemia, obesity, and lipodystrophy. These metabolic disturbances add complexity to the standards of care in HIV infection and further increase the risk for cardiovascular disease and renal complications. The co-association of diabetes and HIV needs to be managed appropriately to prevent mortality and morbidity and improve patient outcome. The current understanding of diabetes and other metabolic abnormalities along with management strategies in HIV infected patients are summarized in this article. The review also focuses on recent challenges in the diagnosis and management of co-existent diabetes and HIV infection.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type I Diabetes II: Pathophysiology
Diabetes Mellitus: Introduction
Type II Diabetes II: Pathophysiology
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...

